Tag: lawsuits

  • Woman Sues After Faulty Drug Test Mistakes Cotton Candy For Meth

    Woman Sues After Faulty Drug Test Mistakes Cotton Candy For Meth

    The Georgia woman spent four months in jail because of a faulty roadside drug test mistook her cotton candy for meth.

    A Georgia woman has filed suit after spending almost four months in jail following a faulty roadside drug test that wrongly flagged a baggie of blue cotton candy as crystal meth, according to USA Today.

    Dasha Fincher’s federal legal claim, filed Thursday, targets the county commissioners, the deputies who arrested her and the company that makes the test.

    The arrest that started it all stemmed from a traffic stop on New Year’s Eve in 2016. Two deputies pulled over Fincher and her boyfriend after spotting dark window tints on their car – though authorities later admitted dark window tints are actually legal.

    Police later wrote that the couple seemed nervous, even though they handed over their IDs and agreed to a search of the car. During that search, the lawmen found a plastic baggie with something blue inside. 

    One of the deputies did a roadside test on the hood of the car – and told her he’d found methamphetamine.

    “I knew it was cotton candy,” she told the New York Times, “and for him to come back and say it was meth, I really didn’t know what to say.”

    For close to the next four months, Fincher was held in the county jail on $1 million bail, missing family events – like the birth of her grandsons. 

    “It seemed like everything was going on and I wasn’t there,” she told the Times. “I wasn’t there for my family when they needed me.”

    Then, on March 22 a crime lab finally realized there were no drugs in the bag. But it wasn’t until the following month that the results were finally forwarded to local prosecutors, and on April 4 Fincher was released.

    “It was crystal-like substances, it was in a cellophane bag, and it was under the floor mat,” Elizabeth Bobbitt, the interim district attorney for the area, told the New York paper. “We are not crazy people down here who would like to arrest people for cotton candy.” 

    Roadside drug tests have long been a source of controversy and false positives, as detailed in a 2016 New York Times Magazine and ProPublica investigation

    Based on those $2 tests, officers have wrongly identified everything from motor oil to cat litter to donut glaze as illicit drugs.  

    “Why, it’s almost as if these field tests will say whatever law enforcement officers want them to,” Radley Balko wrote in the Washington Post in 2015.

    In this case, the suit alleges, it was blue food coloring that foiled the test and netted a faulty result.

    The test-maker did not respond to a request for comment.

    View the original article at thefix.com

  • Florida Sues CVS, Walgreens For Their Alleged Roles In Opioid Crisis

    Florida Sues CVS, Walgreens For Their Alleged Roles In Opioid Crisis

    The suit claims that the companies failed to stop “suspicious orders of opioids,” and dispensed “unreasonable quantities” of such drugs.

    The state of Florida has named two of the largest drugstore chains in the United States—Walgreens and CVS—as well as Insys Therapeutics, in a lawsuit that alleged that they “played a role in creating the opioid crisis.”

    Florida Attorney General Pam Bondi issued a press release stating that the pharmacy giants and Insys, which manufactured the fentanyl-based medication Subsys had been added to a state-court lawsuit filed on May 15, 2016 against Purdue Pharma, L.P.—the manufacturer of OxyContin—and other pharmaceutical manufacturers for allegedly contributing to the opioid epidemic with their opioid-based products.

    The suit against CVS and Walgreens alleges that the companies failed to stop “suspicious orders of opioids,” and dispensed “unreasonable quantities” of such drugs from their locations.

    In the complaint, the Attorney General’s Office alleged that Walgreens Co.—the largest drugstore chain in the nation—has distributed vast amounts of opioids throughout the state of Florida, and in some cases, reportedly distributed millions of pills that far outnumbered town populations.

    The suit cites an unidentified Florida town where the Walgreens location is alleged to have sold 285,000 pills in a single month to a town with just 3,000 people.

    According to the suit, some stores reportedly experienced six-fold sales growth for pills in just two years time. Walgreens previously paid a record settlement of $80 million in 2013 for violations of record-keeping and dispensing regulations that allowed oxycodone and other pain medications to be diverted for black market sales.

    The accusations against CVS Healthcare Corp. and CVS Pharmacy, Inc.—the second largest U.S. drugstore chain—claim that the company sold more than 700 million opioid products between 2006 and 2014, including three towns that received and dispensed “huge quantities” of opioids during that time frame.

    CVS also paid $22 million to resolve allegations by the Drug Enforcement Administration (DEA) that retail stores in the town of Sanford, Florida sold painkillers that were not prescribed for “legitimate medical purposes.”

    The suit’s allegations against Insys Therapeutics echo similar charges levied against the troubled pharmaceutical firm, which has been accused of paying doctors to prescribe Subsys, a medication for patients with breakthrough cancer pain, to patients without cancer or similar diagnoses.

    The suit cites public records that showed that Insys paid $18.7 million to doctors between August 2013 and December 2016, including one Florida physician who received $270,000 from the company.

    According to data from the Center for Medicaid and Medicare Services, more prescriptions for Subsys were written in Florida than in any other state.

    A spokesperson for CVS labeled the lawsuit “without merit” and said that in recent years, the company “has taken numerous actions to strengthen our existing safeguards to help address the nation’s opioid epidemic.”

    View the original article at thefix.com

  • Purdue Pharma Accused Of Targeting Seniors For Oxy Sales

    Purdue Pharma Accused Of Targeting Seniors For Oxy Sales

    The lawsuit claims Purdue had salespeople downplay the harmful risks and side effects of OxyContin.

    Oregon’s Department of Justice claims that pharmacy giant, Purdue Pharma, lied to the state and misled customers to drive sales.

    Oregon Attorney General Ellen Rosenblum filed a lawsuit against Purdue Pharma on Thursday, accusing the company of lying to the Oregon State Board of Pharmacy to obtain permission to sell in Oregon, as well as targeting senior citizens with its products.

    The violations against a settlement with Oregon goes back 10 years, according to a June 27 filing. Rosenblum’s office is demanding Purdue submit to the terms of a 2007 settlement or risk legal consequences.

    In the Thursday filing, Rosenblum’s office is demanding Purdue Pharma pay $1 million and abide by a prohibition against marketing to Oregon’s senior citizens.

    According to the lawsuit, Purdue released misleading publications and had its salespeople downplay the harmful risks and side effects of OxyContin, and specifically targeted disabled and senior citizens.

    Purdue also stands accused of lying in its application to renew its license to sell OxyContin in Oregon, erroneously claiming that the company had not faced state or federal punishment. In the past, they’ve been made to pay fines, and some of its top executives faced charges related to the company’s OxyContin marketing practices.

    “Ten years later, it is clear Purdue has flouted the judgment and ignored the severe federal penalties,” reads the lawsuit.

    Advocates for substance abuse prevention lauded the move, praising it as holding pharma companies accountable, to push them to cooperate in combating the opioid epidemic.

    “My hope is that this action will help establish some accountability and bring them to the table to help solve this,” said Dwight Holton, CEO of Lines for Life. “They ought to be helping us and they haven’t been.”

    Representatives of Purdue, however, disagree with this assessment of the situation.

    “We vigorously deny the state’s allegations,” said Purdue spokesperson Robert Josephson, according to the Oregonian. “The state claims Purdue acted improperly by communicating with prescribers about scientific and medical information that FDA has expressly considered and continues to approve. We believe it is inappropriate for the state to substitute its judgment for the judgment of the regulatory, scientific and medical experts at FDA. We look forward to presenting our substantial defenses regarding this lawsuit.”

    Working to improve its image in the shadow of the opioid crisis, Purdue has eliminated 350 sales positions, closed its “speakers” program that paid doctors and other professionals to sing OxyContin’s praises, and reshuffled its efforts towards researching cancer-fighting drugs.

    However, the opioid crisis has already damaged the state. Oregon saw a spike in opioid-related deaths in this past year, with Oregon’s Jackson County seeing a 70% increase in such deaths in just the first quarter of this year.

    View the original article at thefix.com